LCC was created in October 2019 in Astana, Republic of Kazakhstan.
Main activity
The main activity of the laboratory is the implementation of the bio-analytical part of the bioequivalence studies and the Phase I clinical trials of medicines. The mentioned studies are carried out in a complex way, including pharmacokinetic and statistical analysis, as well as the final report.
We have a large number of validated bioanalytical methods (about 200 analytes), already used in bioequivalence studies, (more than 200 analytes), widely tested in practice, and research departments allow us to introduce new methods into practice.